C83.21 Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, lymph nodes of head, face, and neck

Name of the Condition

• Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, lymph nodes of head, face, and neck
• Also known as ICD-10 code C83.21

Summary

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of both small and large lymphoid cells in a diffuse pattern. It typically involves abnormal growth of B-cells or T-cells in the lymph nodes of the head, face, and neck, without forming follicular structures. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior depending on the specific cell composition and distribution.

Causes

The exact cause of mixed small and large cell (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the head, face, or neck.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis involves a combination of physical examination, imaging tests (e.g., CT or PET scans) to identify affected areas, biopsy of lymph nodes or tissues for laboratory analysis, and blood tests to assess overall health and detect abnormal cell markers.

Treatment Options

• Chemotherapy: Systemic drugs to target and kill cancer cells.
• Immunotherapy: Uses the body's immune system to fight cancer cells.
• Radiation Therapy: High-energy radiation to target localized tumors.
• Targeted Therapy: Drugs that target specific cancer cell characteristics.

Prognosis and Follow-Up

Prognosis varies based on factors like stage, cell type, and overall health. Regular follow-up appointments, imaging, and blood tests are typically recommended to monitor for recurrence or progression. Treatment response and long-term outcomes depend on individual case characteristics.

Complications

• Spread of cancer to other lymph nodes or organs.
• Infection due to weakened immune system.
• Side effects from treatment, such as fatigue or nausea.
• Lymphedema (swelling) in affected areas.

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known carcinogens, such as tobacco or excessive alcohol.
• Practice good hygiene to reduce infection risk.
• Follow recommended screening guidelines for high-risk individuals.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or night sweats. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

When coding for C83.21, ensure the documentation specifies the involvement of lymph nodes in the head, face, or neck. Verify that the diagnosis aligns with the mixed small and large cell (diffuse) non-Hodgkin's lymphoma subtype and that the site is clearly documented to support accurate code assignment.